ArticleOTA international : the open access journal of orthopaedic trauma2026
Intramedullary nailing with an absorbable antibiotic bone graft substitute in fracture-related infections and osteomyelitis: a case series.
Article in OTA international : the open access journal of orthopaedic trauma, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Threaded Antibiotic-Coated Locking Nails in Osteomyelitis-Associated Long-Bone Non-Union: Short-Term Outcomes of a Prospective Cohort.Healthcare (Basel, Switzerland) · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objectives: Fracture-related infections (FRI), infected nonunions, and osteomyelitis with bony instability require aggressive treatment involving systemic antibiotics and surgical debridement. Adjuvant local antibiotic therapy delivers higher and sustained concentrations directly to the site of infection while minimizing systemic toxicity. Antibiotic-loaded poly-methyl methacrylate remains a standard option but presents significant limitations, including nonbiodegradability, reduced antibiotic elution over time, and the need for subsequent removal. Cerament G is a bioabsorbable bone void filler composed of calcium sulfate, hydroxyapatite, and gentamicin sulfate. It provides sustained high-dose antibiotic release, promotes osteoconduction, and remodels into bone within 6 to 12 months, eliminating the need for removal. This makes Cerament G a compelling option for the treatment of FRI and osteomyelitis. Methods: We describe a technique and case series using the Reamer-Irrigator-Aspirator (RIA) system, Cerament G injection via the 2Can device, and, when necessary, intramedullary nailing for the treatment of FRI and osteomyelitis. The technique was applied to 7 patients at a single Level-1 Trauma Center from 2022 to 2024 with FRI or osteomyelitis. Intramedullary nailing was performed in cases of nonunion or bony instability. Results: The mean age of patients was 35 years, with a mean body mass index of 29.2. Three patients required adjuvant intramedullary nailing for stabilization. All patients were weight bearing as tolerated after surgery. At a mean follow-up of 14.4 months (6-21 months), there were no recurrence of infection, major complications, or amputations. Conclusion: The combination of Cerament G and the RIA system represents a viable solution for FRI and osteomyelitis providing effective infection control and sustained antibiotic elution. This technique presents a promising alternative to traditional methods, although larger and longer-term studies are needed to confirm its efficacy.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.